HydroVax-002 YFV

Developed for: yellow fever
Investigated by: Najit Technologies, Inc. · National Institute of Allergy and Infectious Diseases (NIAID)

today NCT05172544 · Ph 1

20222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT05172544	Jan 2022 → Apr 2023	yellow fever	Najit Technologies, Inc.	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	HydroVax-002 YFV	ClinicalTrials.gov intervention name — accepted as the source's own label NCT05172544 ↗
Modality	Vaccine	“Inactivated YFV vaccine” NCT05172544 ↗
Route	Intramuscular	“given intramuscularly on Day 1 and Day 29” NCT05172544 ↗